Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Closed-loop tACS Modulation for the Core Clinical Features of Drug Addiction

NCT: NCT06454474 · COMPLETED

NCT IDNCT06454474
StatusCOMPLETED
Start Date2024-06-30
Completion2025-06-30

Brief Summary

Using specific EEG biomarkers in methamphetamine-dependent individuals, this study systematically probes the effect of closed-loop tACS based on brain states

Frequently Asked Questions

What is Closed-loop tACS Modulation for the Core Clinical Features of Drug Addiction?

Closed-loop tACS Modulation for the Core Clinical Features of Drug Addiction is a clinical trial registered under NCT06454474. Current status: COMPLETED.

What is the status of NCT06454474?

The current status of NCT06454474 (Closed-loop tACS Modulation for the Core Clinical Features of Drug Addiction) is: COMPLETED.

When did Closed-loop tACS Modulation for the Core Clinical Features of Drug Addiction start?

Closed-loop tACS Modulation for the Core Clinical Features of Drug Addiction started on 2024-06-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑